|
| 產(chǎn)地 | France |
| 品牌 | AntibodySystem |
| 保存條件 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -310°C long term. |
| 貨號 | DHC90714 |
| 用途 | 類似物，陽性對照抗體 |
| 應(yīng)用范圍 | 類似物，陽性對照抗體 |
| 抗原來源 | Mammalian cells |
| 保質(zhì)期 | 1 year |
| 抗體名 | Research Grade Glofitamab |
| 是否單克隆 | 是 |
| 克隆性 | 是 |
| 靶點 | Bispecific |
| 適應(yīng)物種 | Human |
| 形態(tài) | Liquid |
| 宿主 | 是 |
| 標記物 | Unconjugate |
| 包裝規(guī)格 | 100ug |
| 亞型 | IgG |
| 標識物 | Unconjugate |
| 濃度 | 1mg/ml% |
| 免疫原 | Human |
| 是否進口 | 是 |
Tags: Glofitamab ( 格菲妥單抗 ) supplier,Glofitamab ( 格菲妥單抗 ) purchase,Glofitamab ( 格菲妥單抗 ) manufacturer,Glofitamab ( 格菲妥單抗 ) distributor,Glofitamab ( 格菲妥單抗 ) cost,Glofitamab ( 格菲妥單抗 ) buy,Glofitamab ( 格菲妥單抗 ) for sale
Glofitamab is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells. Glofitamab is an investigational, T-cell bispecific antibody with a distinctive design that features 2 Fab arms for binding CD20 on B cells, along with 1 Fab arm for binding CD3 on T cells. The CD3 binding arm is fused directly to one of the CD20-binding arms in a head-to-tail fashion via a short flexible linker.
DHC90714
Humanized
Human
1mg/ml
>95%
Monoclonal
IgG1-kappa-lambda
Research Grade Glofitamab Biosimilar
Bispecific,B-lymphocyte surface antigen B1,Membrane-spanning 4-domains subfamily A member 1,MS4A1,Leukocyte surface antigen Leu-16,B-lymphocyte antigen CD20,Bp35,CD20,T3E,T-cell surface antigen T3/Leu-4 epsilon chain,CD3e,T-cell surface glycoprotein CD3 epsilon chain
Protein A or G purified from cell culture supernatant.
Please contact with the lab for this information.
Mammalian cells
P11836 & P07766
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Bispecific, CD20-TCB (2:1), RG-6026, CAS: 2229047-91-8
For research use only. Not suitable for clinical or therapeutic use.
Aiming to develop the most reliable bioreagents, AntibodySystem SAS was founded in 2019 in France by a team of professionals from top industrial companies and research institutes. The collective scientific and technical experiences in our team have brought breaking throughs in multiple product developments, including recombinant antibodies, recombinant proteins, biosimilar, RUO ELISA kits and other related products. By working with talented researchers and technicians, AntibodySystem continues to upgrade product qualities and lower the overall cost, offering accountable and affordable solutions for biolabs all over the world. Since its establishment, AntibodySystem has built long term and stable collaborations with academia, pharmaceutical industry, biotech companies and research hospitals, supporting their R&D by AntibodySystem's bioreagents with excellent data accuracy and reproducibility.
AntibodySystem由具有30多年蛋白抗體開發(fā)經(jīng)驗的 創(chuàng)立于法國,專注于生命科學(xué)和生物制藥領(lǐng)域研究,總部位于法國斯特拉斯堡市。AntibodySystem自主開發(fā)了高效、高產(chǎn)的真核重組表達系統(tǒng),利用該系統(tǒng)生產(chǎn)了高質(zhì)量的重組蛋白、抗體產(chǎn)品。目前產(chǎn)品包括藥物靶點蛋白以及對照抗體藥物、Invivo功能性抗體、SAA系列流式抗體、PEG抗體、磷酸化抗體、抗小分子抗體、ADA抗體、PK&ADA ELISA試劑盒。
普健生物作為AntibodySystem在亞洲區(qū)授權(quán) ,致力于為廣大科研工作者提供 的產(chǎn)品服務(wù)。
如果您對我們的產(chǎn)品感興趣,請聯(lián)系027-65279366。
以上產(chǎn)品僅用于科研,產(chǎn)品信息以產(chǎn)品 為準
